FindTrial
Sign In

The Impact of Multiple-Dose vs. Single-Dose Pulmonary Surfactant on Outcomes in Extremely Preterm Infants: A Study Based on a Standardized Delivery Room CPAP Cohort

The Impact of Multiple-Dose vs. Single-Dose Pulmonary Surfactant on Outcomes in Extremely Preterm Infants: A Study Based on a Standardized Delivery Room CPAP Cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113418
Enrollment
Unknown
Registered
2025-11-27
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NRDS?BPD

Interventions

Control group:None
Observation group:None

Sponsors

Chongqing Health Center for Women and Children
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Neonates with gestational age <32 weeks; 2.Admitted to the hospital within 24 hours after birth;

Exclusion criteria

Exclusion criteria: 1.Significant congenital malformations; 2.Did not receive CPAP during resuscitation.

Design outcomes

Primary

MeasureTime frame
BPD;—

Secondary

MeasureTime frame
Safety Outcomes;Short-time Outcomes;Long-term Outcomes;Complication;—

Countries

China

Contacts

Public ContactZhang Xiaoting

Chongqing Health Center for Women and Children

37299215@qq.com+86 23 60354473

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026